Logotype for Newbury Pharmaceuticals

Newbury Pharmaceuticals (NEWBRY) investor relations material

Newbury Pharmaceuticals Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Newbury Pharmaceuticals
Q4 2025 earnings summary29 Oct, 2025

Executive summary

  • Q4 turnover was significantly impacted by lower-than-expected tender wins, delayed product launches, and high competition, resulting in a sharp revenue decline year-over-year.

  • Full-year net revenue decreased to 31,573 tkr from 36,829 tkr, with EBITDA falling to -16,299 tkr from -12,340 tkr.

  • Nordic sales grew year-over-year, but international sales dropped sharply, affecting overall performance.

  • Product portfolio expanded, with 30 licensed products and 29 with marketing authorization at year-end.

Financial highlights

  • Q4 net revenue was 5,915 tkr, down from 21,123 tkr in Q4 last year.

  • Full-year EBITDA was -16,299 tkr, compared to -12,340 tkr the previous year.

  • Operating result (EBIT) for the year was -21,966 tkr, down from -14,078 tkr.

  • Cash position at year-end was 14,562 tkr, slightly lower than last year.

  • Equity at year-end was 42,754 tkr, with equity per share at 1.41 kr.

Outlook and guidance

  • Q1 2025/2026 is expected to see record Nordic sales, but international business will remain weak until regulatory issues are resolved in 2026.

  • The product portfolio is projected to reach over 30 launched products by December 2026, supporting future sales growth.

  • Negative operating cash flow is expected to persist due to ongoing expansion.

Timeline for international business recovery?
Liraglutide failure: partner compensation details?
What specific funding measures are planned?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Newbury Pharmaceuticals earnings date

Logotype for Newbury Pharmaceuticals
Q1 202614 Jan, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Newbury Pharmaceuticals earnings date

Logotype for Newbury Pharmaceuticals
Q1 202614 Jan, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Newbury Pharmaceuticals AB is a Sweden-based company specializing in specialty prescription drugs. The company's portfolio includes products across therapeutic areas such as oncology, rare diseases, and neurology. Newbury Pharmaceuticals primarily serves the Scandinavian market, focusing on developing both proprietary and licensed pharmaceutical products. The company is headquartered in Lund, Sweden, and its shares are listed on the Stockholm Stock Exchange.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage